RazorMetrics, a leading innovator in pharmacy technology solutions, today announced the launch of its Polypharmacy Solution, designed to tackle the growing challenges of medication overload and rising ...
Reports preliminary fourth quarter 2024 revenue in the range of approximately $19.2 million to $19.4 millionReports preliminary full-year 2024 revenue in the range of approximately $73.1 million to ...
A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.